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This study was performed to investigate the theraputic efficacy of toltrazuril, sulfaclozine sodium and their 
combination in broiler chicken for the treatment of experimentally induced caecal coccidiosis. For this purpose, 
seventy-five day-old chicks were randomly divided into five equal groups (15 each). G1, kept as control negative; G2, 
infected non treated (control positive); G3, infected treated with toltrazuril (1 mL/L); G4, infected treated with 
sodium sulfaclozine (2 mL/L); G5, infected treated with toltrazuril (1 mL/L) + sulfaclozine Na (2 g/L). All groups 
except negative control group were inoculated orally with 5 × 104 sporulated oocysts of Eimeria tenella (field isolate) 
on the day 15th of age. According to the present results, G2 showed a significant increase in oocyst count, AST, ALT, 
ALP, uric acid, and creatinine, with significant decrease in body weight gain, hematological parameters, total 
protein, and albumin. Treatment decreased the harmful effect of infection but some significant differences were shown 
between infected and treated groups and non infected and non treated group in assessment criteria. Furthermore, the 
histopathological findings were also discussed. In conclusion, the current study showed that the application of both 
tested drugs gave significant and satisfactory improvement in the assessment criteria as well as they are effective in 
control of coccidiosis caused by Eimeria tenella.
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ABSTRAK
Kajian ini dilakukan untuk mengkaji keberkesanan terapeutik toltrazuril, natrium sulfaklozina dan gabungannya 
pada ayam pedaging untuk rawatan terhadap koksidiosis sekum teraruh uji kaji. Bagi tujuan ini, anak ayam berusia 
tujuh puluh lima hari dibahagikan secara rawak masing-masing kepada lima kumpulan yang sama (15 kumpulan). 
G1, sebagai kawalan negatif; G2, dijangkiti dan tidak dirawat (kawalan positif); G3, dijangkiti dan dirawat dengan 
toltrazuril (1 mL/L); G4, dijangkiti dan dirawat dengan natrium sulfaklozina (2 g/L); G5, dijangkiti dan dirawat dengan 
toltrazuril (1 mL/L) + natrium sulfaklozina (2 g/L). Semua kumpulan kecuali kumpulan kawalan negatif disuntik 
secara lisan dengan 5 × 104 oosista sporulasi bagi Eimeria tenella (medan terasing) pada hari ke-15. Hasilnya, G2 
menunjukkan peningkatan yang signifikan dalam jumlah oosistacre, AST, ALT, ALP, asid urik dan kreatinin, dengan 
penurunan yang signifikan dalam kenaikan berat badan, parameter hematologi, jumlah protein dan albumin. Rawatan 
telah mengurangkan kesan berbahaya disebabkan jangkitan tetapi beberapa perbezaan ketara ditunjukkan antara 
kumpulan yang dijangkiti dan dirawat dan kumpulan yang tidak dijangkiti dan tidak dirawat dalam kriteria penilaian. 
Tambahan pula, penemuan histopatologi juga dibincangkan. Kesimpulannya, kajian semasa menunjukkan bahawa 
penggunaan kedua-dua ubat yang diuji memberikan peningkatan yang ketara dan memuaskan dalam kriteria penilaian 
serta berkesan juga dalam mengendalikan koksidiosis yang disebabkan oleh Eimeria tenella.
Kata kunci: Ayam pedaging; jangkitan uji kaji E. tenella; Mesir; natrium sulfaklozina; toltrazuril
INTRODUCTION
Chickens considered as a good source of high biological 
value animal protein for human consumption. Rising 
of public awareness of the poultry industry will likely 
continue to make proper prevention and treatment of 
several diseases, of which avian coccidiosis. Coccidiosis 
is still major problems worldwide; caused by a single-cell 
protozoan parasite belonging to the genus Eimeria. It has 
a significant economic impact on poultry by reducing 
performance and decreasing productivity, with high rate of 
mortality and morbidity (Abbas et al. 2017). Conventional 
control of this problem based mainly on managerial skills 
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and the use of anticoccidial drugs (Tewari & Maharana 
2011). 
Synthetic anticoccidial drugs remain the mainstream 
agents used in control of chicken coccidiosis globally. 
Moreover, anticoccidial compounds should be highly 
effective against all developmental stages of Eimeria 
species, do not  disturb the host immune response as well as 
have no residues in the tissues. In this respect, Toltrazuril, 
a triazinetrione derivative is licensed drug for not only as 
prophylactic agent but also as curative drugs against all 
developmental stages of Eimeria spp. (Shivaramaiah et 
al. 2014). Toltrazuril interferes with the division of the 
nucleus and with the activity of the mitochondria, which 
is responsible for the respiratory metabolism of Coccidia. 
In the macrogamete, toltrazuril damages the so-called 
wall-forming bodies. In all intracellular developmental 
stages, severe vacuolization occurs due to inflation of the 
endoplasmic reticulum (Harfoush et al. 2010; Ramadan 
et al. 1997).
On the other hand, Sulfaclozine sodium is an 
efficacious sulphonamide derivative with antibacterial 
and anticoccidial effect (Li & Bu 2014). As other 
sulfonamides, it has a good  coccidiostatic  effects 
on  control  and  treatment  of chicken coccidiosis in 
experimental and    natural infection (McDougald & Fitz-
Coy 2008). Sulfaclozine is a competitive antagonist of para-
aminobenzoic acid (PABA), a precursor of folic acid, in 
protozoa and bacteria. Folic acid is a coenzyme necessary 
for the synthesis of nucleic acid; hence sensitive species 
do not multiply in the presence of sulfaclozine (Harfoush 
et al. 2010). Furthermore, feeding of sulfonamides may 
prevent clinical signs and reduce oocyst production thereby 
allowing development of protective  immunity. 
As the world’s poultry industry continues to grow, 
so does concerns about the control of coccidiosis, which 
remains one of the most commonly reported disease of 
chickens (Xie et al. 2001). Therefore, the present study 
was conducted to investigate the anticoccidial efficacy 
of toltrazuril, sulfaclozine sodium and their simultaneous 




Toltrazuril oral solution (Kimzuril 2.5%®), each 100 g 
containing 2.5 g toltrazuril. It is recommended at level of 
1 mL kimzuril/liter of drinking water for three successive 
days. Sulfaclozine sodium monohydrate water soluble 
powder (sulfaclozimed 30%®), each 100 g contains 30 g 
sulfaclozine sodium monohydrate. It is recommended at 
level of 2 g sulfaclozimed/liter of drinking water for three 
successive days. The two drugs were purchased from 
Arab company for medical products, Egypt.
EXPERIMENTAL BIRDS
A total of 75 one-day old Erbo plus strain chicks from 
Taraq Deiab Farm, Kotor, Egypt with an average body 
weight of 45 to 50 g were used in these trials. The birds 
were kept in individual well-isolated floor pens with 
wood shaving litter, plastics waters, and feeders. All 
tested birds were fed a standard commercial diet and were 
formulated without any anticoccidial medication (Abd El-
Salam Hegazy Company, Cairo, Egypt). Strict sanitation 
practices were maintained in the experimental house 
before and during the course of experiment. Temperature 
was adjusted according to the age (at the first week of age 
it was 32 °C and decreased 2 °C per week till reached 26 
°C at one month of age and was fixed at this degree till 
the end of experiment. Continuous light was also provided 
throughout the experimental period (Harrison & Harrison 
1986). Furthermore, Birds were vaccinated against 
infectious bronchitis, Newcastle disease and infectious 
bursal disease according to the standard schedule.
PREPARATION OF Eimeria INFECTION
Eimeria tenella oocysts were collected from ceci of 
naturally infected chickens. The infected chickens were 
selected from a commercial broiler farm obtained from 
Alpha Laboratory, Gharbia governorate, Egypt. The 
protocol of isolation and preparation of E. tenella oocyst 
was performed according to Lovelu et al. (2016). The 
cecal contents were homogenized with water and sieved 
in a beaker through a fine wire mesh. The filtrate was 
let to sediment, the supernatant was discarded and the 
pellet was re-suspended in potassium dichromate 2.5% 
in the presence of suitable humidity and temperature 
in a group of petri dishes. The thickness of fluid was 
not higher than 5 mm to facilitate the oxygen diffusion. 
Forced aeration was achieved (2-3 time daily) by 
removing the cover and shaking the suspension for few 
minutes. The plates were examined microscopically to 
assign the degree of sporulation. After sporulation, the 
sporulated oocysts were removed from the fecal debris 
by a series of centrifugation using NaCl (concentration 
flotation technique). The suspension was centrifuged  at 
a moderate speed (1500 rpm) for 5-10 min to allow the 
oocysts to suspend at the top of supernatant and sediment 
the solids. The floated oocysts were collected by Pasteur 
pipette. Sporulated oocysts count (oocysts per gram of 
feces, OPG) was estimated by the use of the Mc Master 
technique (Lloyd & Soulsby 1978). The coccidial species 
were microscopically identified following its sporulation 
in 2.5% solution by using morphological parameters 
(Eckert et al. 1995).
EXPERIMENTAL DESIGN
The chickens were weighed and randomly divided at 
15th day of age into five equal groups (each of 15) as the 
following: 
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Group1: non-infected non treated (control negative). 
Group2: infected non treated (control positive). Group3: 
infected treated with toltrazuril (1 mL/L). Group4: infected 
treated with sulfaclozine sodium (2 g/L). Group5: infected 
treated toltrazuril with (1 mL/L) + sulfaclozine sodium 
(2 g/L).
Except G1, all groups were infected with 5 × 10
4 oocysts of 
E. tenella (field isolate) orally by direct administration 
into the crop using rubber syringe on day 15th of the 
experiment (Harfoush et al. 2010). Moreover, the 
application of drug treatment was started at day 20th of age 
and continued for three successive days.
ASSESSMENT CRITERIA
CLINICAL SIGNS AND GROWTH PERFORMANCE 
MEASUREMENTS
Throughout the experiment, the morbidity and the 
numbers of dead birds were recorded daily representing 
the mortality rate, beside any obvious clinical signs were 
also recorded. Furthermore, birds were individually 
weighted weekly, beginning from 15th day of age. The 
weight gain was calculated by subtracting the initial 
weight of birds from the final weight of the birds. Feed 
conversion ratio (FCR) was calculated using the following 
formula: FCR = Feed consumption in a given period/ 
gain produced in the same period (El-Ghoneimy & El-
Shahawy 2017).
  
NUMBER OF OOCYSTS PER GRAM (OPG) OF FAECES
The reduction of oocyst output was taken as a criterion 
for the efficacy of tested drugs. The faecal samples were 
collected on day 0 (pretreatment) at 20 days old and 
consequently at day 1 till 13 days post coccidian treatment 
(from 21 till 33 days old). The oocysts counting were done 
through Mc Master Techniques as described by Chand 
et al. (2016). Additionally, the percentage efficacy for 
tested drugs was determined (Moskey & Harwood 1941).
LESION SCORE
Five birds were sacrificed/group at 8th and 22nd days post 
infection for demonstration of macroscopical caecal 
lesion score. The lesions were scored on a scale of 0 to 
+4 according to the severity of the lesions (Johnson & 
Reid 1970). A score (0) denoted no lesions whereas (+4) 
denoted severe lesion. 
HEMATOLOGICAL AND BIOCHEMICAL ANALYSIS
Two blood samples were collected from each group 
(five birds/group) at 23th and 37th days of age. For 
hematological parameters, about 1 mL of blood 
was withdrawn from the wing vein and immediately 
transferred into sterile test tube containing 1 mg EDTA as 
an anticoagulant. Complete blood picture (hemoglobin 
concentration, packed cell volume, red blood cell count, 
white cells count, and differential leucocyte count) 
were calculated (Reagan et al. 2019). For biochemical 
analysis on the other hand, blood was collected without 
anticoagulant for serum biochemistry determination. 
Serum was separated after centrifugation at 3000 rpm for 
15 min and stored at -20 oC until tested. Serum aspartate 
aminotransferase (AST), alanine aminotransferase (ALT) 
(Reitman & Frankel 1957), alkaline phosphates (Kind & 
King 1954), total serum protein (Henry 1964), albumin 
(Doumas et al. 1971), creatinine (Henry 1974) and uric 
acid (Barham & Trinder 1972) were measured. 
HISTOPATHOLOGICAL EXAMINATION
Tissue specimens from cecum, liver, and kidney were 
taken from chickens in all groups (five birds/group) at the 
day 23th and 30th of age. Specimens fixed in 10% neutral 
formalin before dehydration in ascending grading of ethyl 
alcohol, followed by clearing in xylene and processed 
in paraffin wax cubes. Specimens cubes were sectioned 
at 5 μm thickness, then stained with haematoxylin and 
eosin (H&E) according to the method described by Pop 
et al. (2015). The count of the parasitic stages within the 
intestinal tissues was performed blindly and expressed 
as the average number/mm2 in about 8 HPF. Regarding 
to histological scoring of both hepatic and renal lesions, 
eight points score was assessed according 4 parameters (2 
points to each) including vascular lesions as congestion 
and hemorrhage, degenerative changes, necrosis, and 
inflammation. Each parameter was assessed as 0 no 
obvious lesions, 1 mild changes and 2 advanced diffuse 
changes.  
STATISTICAL ANALYSIS
All the data were expressed as means ± standard 
deviation (SD). The statistical significance evaluated 
by one-way analysis of variance (ANOVA) using the 
statistical software program (SPSS, ver.16.00, USA). Values 
were considered statistically significant at (p ≤ 0.05).
RESULTS
 
CLINICAL SIGNS AND MORTALITY RATE
In this study, the birds in the infected non treated group 
(G2) showed ruffled feathers, huddling, depression, loss 
of appetite, anorexia, and intensive bloody diarrhea, which 
began on the 6th day post-infection. These signs severed 
by 7th day post-infection and subsided gradually with the 
observation of few discolored droppings and varying 
degrees of depression until the end of the experiment. 
This signs declined after treatment with toltrazuril (G3), 
and sulfaclozine sodium (G4) each alone or in combination 
(G5) and chickens were more apparently healthy during this 
period. Moreover, the mortality % in G2 was 33.33% and it 
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was reduced to 13.33% in G4, with no mortality observed 
in G3, G5 (Table 2).
GROWTH PERFORMANCE
Infected non treated group (G2) showed a significant 
(p ≤ 0.05) decrease in the body weight gain with poor 
feed conversion ratio. Moreover, there was a significant 
improvement in these growth performance parameters in 
G3, G4 and G5 as compared with G2 (Table 1).
OOCYST OUTPUT AND LESION SCORE
The infected non treated control group (G2) showed the 
highest oocyst counting which reached its maximum 
count on the 8th day post infection. This highest oocyst 
counting was significantly decreased after treatment with 
toltrazuril (G3) and sulfaclozine sodium (G4) each alone 
or in combination (G5) (Table 3). Based on percentage of 
reduction in the OPG in faeces, it can be concluded that 
the combination between Toltrazuril and Sulfaclozine 
sodium (G5) was superior followed by Toltrazuril alone 
(G3) and Sulfaclozine sodium alone (G4), respectively 
(Table 3). On the other hand, the caeca of the infected non 
treated group (G2) showed the highest lesion scores which 
ranged from +3 to +4. The lesion scores were improved by 
all drugs treatments and ranged from +1 to +2 in G4 and 
from 0 to +1 in G3, G5. 
HEMATOLOGICAL AND BIOCHEMICAL PARAMETERS
Infected non treated group (G2) showed a significant 
decrease in RBCs count, Hb concentration and PCV% at 
23th and 37th days of age compared with control group 
(G1). This decreased number was significantly increased 
after treatment with toltrazuril (G3) and sulfaclozine 
sodium (G4) each alone or in combination (G5). There was a 
marked increase of the total leucocytic count, lymphocytes, 
heterophils, monocytes, and eosinophils in infected non 
treated group (G2) and treated groups (G3, G4, G5) then 
changed by time towards the normal value till the end of 
the experiment. With regarding G2, there was a significant 
increase in total leucocytic count and eosinophils at 37 
days of age when compared with G1 (Tables 4 & 5).
Infected non treated group (G2) showed a significant 
increase in serum AST, ALT, ALP, uric acid, and creatinine, 
with a significant decrease in total protein and albumin 
compared with G1 at 23
th and 37th days of age. Moreover, 
infected treated groups (G3, G4, G5) showed a significant 
decrease in AST, ALT, uric acid, and creatinine and 
a significant increase in total protein and albumin 
compared with G2 (Tables 6 & 7).
HISTOPATHOLOGICAL FINDINGS
Quantitative scoring of the histopathological findings 
as illustrated in Figures 1 to 3. The cecal, hepatic, and 
renal scores markedly elevated in G2. While the different 
tissue scores decreased in treated groups (G3, G4, & G5). 
The parasitic stages count in cecal tissue significantly 
reduced in all treated groups. G5 showed a significant 
decrease of coccidial stages in comparison with G3 and 
G4 (P ≤ 0.05). However, the hepatic and renal scores in 
G5 did not show any significance in compared with every 
single treatment.
On the 23rd, the histological examination of cecal 
sections of G1 showed normal mucosal folds with normal 
intestinal crypts. G2 showed necrotic enteritis associated 
with partial or complete sloughing of the mucosa as 
most of intestinal gland showed presence of coccidial 
schizonts. Some of the parasitic stages were extended 
to the muscle layer associated with extensive necrosis, 
inflammation, and marked inflammatory cells infiltrated 
such as heterophils, eosinophils, and mononuclear cells. 
G3 showed a marked decrease in the necrotic lesion 
accompanied by decreasing the parasitic stages within 
lining mucosa and hyperplastic regenerative changes 
seen within the mucosal lining. Similarly, G4 showed to 
decrease the parasitic stages and necrotic enteritis but 
with a lesser degree than G3. G5 showed a marked decrease 
in parasitic stages, mild degenerative and hyperplastic 
changes within the mucosa. The liver of G1 showed 
normal hepatic tissues. G2 showed multifocal periportal 
inflammation consisted of mononuclear cell infiltration 
mixed with eosinophils. G3 showed a mild to moderate 
degree of portal inflammation. G4 showed to a marked 
degree of hepatic vacuolation and degeneration. The liver 
of G5 showed periportal inflammatory cell infiltration. 
The kidney of G1 showed normal renal glomeruli and 
tubules. G2 demonstrated coagulative necrosis of the renal 
tubules. G3 showed mild degenerative change of renal 
tubules. G4 showed degenerative changes within the renal 
tubules such as vacuolation, myelin membrane on the 
renal tubules epithelial lining and hyaline cast. G5 showed 
similar lesions of G4.
On the 37th, the cecal mucosa was improved than 
the previous sacrifice, unless G2 showed the still presence 
of parasitic stages seen within the lamina propria and 
muscle layer. Meanwhile, G3, G4, and G5 showed a marked 
decrease of coccidial stages which mostly noticed as a 
dead vacuolated cyst. The liver of G2 showed still periportal 
inflammation consisted mainly of mononuclear cells 
and an abundant number of eosinophils. Also, the kidney 
showed degenerative changes within the renal tubules 
with marked regenerative tubular basophilia. The liver 
and kidney of G3 were showed mild lesion while G4 and 
G5 showed moderate degenerative changes of the renal 
tubular epithelium. 
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TABLE 1. Body weight gain (g) and feed conversion ratio (FCR) (mean±SD) in control and treated groups
Groups
Body wt. gain Feed conversion ratio (FCR)
At day 22 At day 29 At day 36 At day 22 At day 29 At day 36
G1 444.7±12.15
a 591.05±25.97a 714.09±25.14a 1.38±0.02c 1.35±0.03c 1.49±0.06c
G2 264.79±11.15
c 524.13±11.24b 527.27±30.59b 1.89±0.05a 1.43±0.01a 1.7±0.01a
G3 352.6±13.76
b 585.59±14.15a 683.46±20.19a 1.68±0.03b 1.31±0.02b 1.59±0.05b
G4 344.67±16.76
b 584.33±16.35a 674.23±17.73a 1.71±0.06b 1.30±0.03b 1.6±0.02b
G5 338.93±19.73
b 587.56±16.14a 690±19.16a 1.77±0.02b 1.32±0.01b 1.57±0.03b
Means within rows with different superscripts differ at P ≤ 0.05. G1: Non-infected non-treated. G2: Infected non-treated. G3: Infected, treated by toltrazuril. G4: Infected, 
treated by sulfaclozine sodium. G5: Infected, treated by toltrazuril + sulfaclozine sodium
TABLE 2. Lesion score and mortality % in control and treated groups
Mortality %NO. of deaths
Lesion score






G1: Non-infected non-treated. G2: Infected non-treated. G3: Infected, treated by toltrazuril. G4: Infected, 
treated by sulfaclozine sodium. G5: Infected, treated by toltrazuril + sulfaclozine sodium
TABLE 3. Oocysts count (×103)/gram of feces (OPG) (mean± SD) and % of OPG reduction (OPGR%) in infected non treated and 
treated groups (N=5)
Age                    Group
G5





















































































































































Means within rows with different superscripts differ at P ≤ 0.05. G1: Non-infected non-treated. G2: Infected non-treated. G3: Infected, treated by toltrazuril. G4: Infected, 
treated by sulfaclozine sodium. G5: Infected, treated by toltrazuril + sulfaclozine sodium
TABLE 4. Hematological parameters (mean± SD) in control and treated groups at day 23 of age
Groups
Parameters G1 G2 G3 G4 G5
RBCs (×106/μL) 2.72±0.09a 2.41±0.01b 2.25±0.01b 2.3±0.03b 1.44±0.13c
Hb (g/dl) 9.88±0.14a 7.95±0.03b 6.8±0.01d 7.5±0.09c 5.18±0.11e
PCV (%) 33.46±0.38a 27.17±0.09b 24.65±0.04d 26.06±0.25c 23.25±0.45e
WBCs (×103/μL) 14.24±0.82c 16.88±0.24b 17.88±1.02b 17.55±0.21b 19.78±0.41a
Lymphocyte (%) 58.24±0.49b 60.5±0.16b 59.53±0.29b 60.92±0.82b 65.2±1.59a
Heterophil (%) 33.62±0.45c 35.1±1.52b,c 36.77±1.73a,b 35.9±0.39b,c 39.73±0.94a
Eosinophil (%) 3.53±0.23d,e 4.8±0.59b,d 6.1±0.58 a,b 5.3±0.52b,c 7.2±0.25a
Monocyte (%) 3.4±0.29c,d 4.35±0.38b,c,d 5.4±0.59a,b 4.62±0.64b,c 6.6±0.29a
Means within rows with different superscripts differ at P ≤ 0.05. G1: Non-infected non-treated. G2: Infected non-treated. G3: Infected, treated by toltrazuril. G4: Infected, 
treated by sulfaclozine sodium. G5: Infected, treated by toltrazuril + sulfaclozine sodium
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TABLE 5. Hematological parameters (mean ± SD) in control and treated groups at day 37 of age
Groups
Parameters G5G4G3G2G1








Means within rows with different superscripts differ at P ≤ 0.05. G1: Non-infected non-treated. G2: Infected non-treated. G3: Infected, treated by toltrazuril. G4: Infected, 
treated by sulfaclozine sodium. G5: Infected, treated by toltrazuril and sulfaclozine sodium









8.7±0.06b8.5±0.01b,c8.3±0.04c,d9.9± 0.08a6.9±0.051Uric acid (mg/dl)
Means within rows with different superscripts differ at P ≤ 0.05. G1: Non-infected non-treated. G2: Infected non-treated. G3: Infected, treated by toltrazuril. G4: Infected, 
treated by sulfaclozine sodium. G5: Infected, treated by toltrazuril and sulfaclozine sodium
TABLE 7. Biochemical parameters (mean ± SD) in control and treated groups at day 37 of age
Groups
Parameters G1 G2 G3 G4 G5
AST (U/L) 44± 0.03e 88.6±0.04a 70±0.02d 73±0.15c 75.1±0.08b
ALT (U/L) 41±0.28d 85.1±0.49a 67.3±0.59c 67.8±0.54c 71.2±0.24b
ALP (U/dl) 44.27±0.02e 87.9±0.03a 68.6±0.01d 73.2±0.05c 75±0.01b
TP  (g/dl) 3.21±0.05a 1.31±0.05d 2.5±0.06b 1.9±0.03 c 1.8±0.01c
Albumin (g/dl) 2.03±0.01a 0.56±0.01d 0.78±0.01b 0.75±0.02b 0.64±0.01c
Creatinine (mg/dl) 0.5±0.1d 1.33±0.01a 0.7±0.01 c 0.82±0.01b 0.89±0.01b
Uric acid (mg/dl) 7±0.07c 9 ±0.07a 8±0.4b,c 8.3±0.04b 8.4±0.05b
Means within rows with different superscripts differ at P ≤ 0.05. G1: Non-infected non-treated. G2: Infected non-treated. G3: Infected, treated by toltrazuril. G4: Infected, 
treated by sulfaclozine sodium. G5: Infected, treated by toltrazuril and sulfaclozine sodium
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FIGURE 1. A) represents the histological count of coccidial stages, B) represents hepatic score, C) renal 
score. Data expressed as Means with different superscripts differ at P ≤ 0.05. G2: Infected non-treated. G3: 
Infected, treated by toltrazuril. G4: Infected, treated by sulfaclozine sodium. G5: Infected, treated by toltrazuril 
and sulfaclozine sodium
FIGURE 2. Histopathological findings of the cecal, hepatic, and renal tissues of the different groups sacrificed on the 23rd 
day. The first lane represents the cecum, liver and kidney of G1, 2nd lane represents the cecum, liver and kidney of G2, 
3rd lane represents the cecum, liver and kidney of G3, 4th lane represents the cecum, liver and kidney of G4, 5th lane 
represents the cecum, liver and kidney of G5. Arrows indicate parasitic stages; arrowheads reveal periportal inflammatory 
cells infiltration and curved-arrow shows necrotic and degenerative changes within the renal tubules, bar= 100 µm
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DISCUSSION
Toltrazuril and sulfaclozine sodium blocked the 
production of coccidia stages in the cecum, which in 
turn reduced the number of oocysts in feces. Toltrazuril 
is effective against all intracellular developmental 
stages including those of schizogony and gametogenic 
(Mehlhorn et al. 1988). Toltrazuril enhances natural 
immunity (Greif 2000). Due to antibacterial activity, 
the sulfonamide drug prevents secondary bacterial 
infections, which often occur after coccidiosis (Yegani 
& Korver 2008). Sulfaclozine sodium may reduce the 
deleterious effects of coccidiosis in broilers (Ashraf 
2011). It interferes with the synthesis of folic acid, which 
required for deoxyribonucleic acid synthesis (Haritova 
et al. 2013). Therefore, toltrazuril when used alone, or 
in combination with sulfaclozine sodium, has a potent 
anticoccidial effect and improved body weight gain. In 
addition, the slight clinical manifestation of illness all 
over the experimental period, decreased lesion score 
and oocyst output was observed (Ashraf 2011; Lovelu et 
al. 2016).
FIGURE 3. Histopathological findings of the cecal, hepatic, and renal tissues of the different groups sacrificed on the 37th 
day. The first lane represents the cecum, liver, and kidney of G1, 2
nd lane represents the cecum, liver and kidney of G2, 3
rd 
lane represents the cecum, liver and kidney of G3, 4
th lane represents the cecum, liver and kidney of G4, 5
th lane represents 
the cecum, liver and kidney of G5. Arrows indicate parasitic stages; arrowheads show periportal inflammatory cells 
infiltration and curved-arrow shows necrotic and degenerative changes within the renal tubules, bar= 100 µm
 Infection with E. tenella induced a significant decrease 
in RBCs, Hb, and PCV; this may be due to the profuse 
cecal hemorrhages caused by E. tenella infection, which 
leads to anemia. It also induced a significant increase 
in total leucocytic count and differential leucocytic 
count as (lymphocytosis, heterophilia, monocytosis, 
and eosinophilia). These hematological findings were 
in agreement with Adamu et al. (2013) and Akhtar 
et al. (2015). Increase in leucocytic count expressed 
as lymphocytosis, heterophilia, monocytosis, and 
eosinophilia confirmed by Bremner (2018) who stated 
that heterophils are the major phagocytic cells in the 
population of leucocytes, mast cells could play a role 
primary inflammatory cells, eosinophils which mainly 
increased during parasitic infestation, monocytes as 2nd 
line of defense increased in case of protozoal infection 
and lymphocytes which consider as a wandering cells 
by migration during the inflammatory immune response. 
Moreover, hematological parameters markedly improved 
in toltrazuril and toltrazuril plus sulfaclozine sodium 
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treated groups than sulfaclozine sodium only treated group. 
Similar improvement in hematological parameters was 
also recorded by Harfoush et al. (2010) and Youssef et al. 
(2015).
A significant increase in serum ALT, AST, ALP, uric 
acid, and creatinine and a significant decrease in total 
protein and albumin in infected non treated group may 
be due to the impaired liver function and injury of liver 
and kidney parenchyma due to harmful effect of Eimeria 
parasite. These findings are following those obtained by 
Harfoush et al. (2010) who found that infection with E. 
tenella showed unexpected increase in ALT and AST. 
This noticed that although Eimeria infection might not 
have a direct effect on the liver. On the other hand, more 
support could be obtained from the fact that Eimeria 
caused diarrhea and favors secondary bacterial infection 
like clostridia and their toxins may affect the enzymes 
of the liver. The liver is considered the precursor of 
most serum protein. Generally, hypoproteinimia occurs 
in chronic renal, hepatic diseases, malnutrition, and 
malabsorption of nutrients. In the present study, the pattern 
of total protein and albumin indicates hypoprotienimia 
which may be attributed to AL-Saeed et al. (2017) and 
El-Maksoud et al. (2014).
Moreover, Mondal et al. (2011) and Patra et al. (2010) 
reported that, liver function test of the infected broiler 
chickens with Eimeria spp. showed a significant increase 
in the serum ALT, AST. They suggested that significant 
damage of cell lining of the cecal wall along with their 
inflammation, severe blood loss causing tissue loss from 
the body may attribute to increased AST activity, and the 
fall in total plasma protein in the coccidia infected birds 
might be due to acute stress that leads to cortisol secretion 
and catabolism of protein. The noticeably increased serum 
activities of ALP in our study might be associated with the 
metabolic alteration and damage of the bone marrow as 
compensation for the blood losses; the bone marrow might 
force to produce excessive blood cellular components. 
Alkaline phosphatase found mainly in the bone, liver, and 
intestinal wall, with high levels found in young animals 
with high osteoblastic activity (Kerr 2008). The changes 
in the biochemical parameters were significantly improved 
in toltrazuril treated group than sulfaclozine sodium, 
toltrazuril plus sulfaclozine sodium groups. 
Histopathological findings in G2 were in agreement 
with Bould et al. (2009) who reported that this severe 
destruction in cecal mucosal layer, penetrating villus 
epithelial cells resulting in extensive desquamation of the 
cecal epithelium and hemorrhagic feces due to the initial 
adherence and invasion of E. tenella to the intestinal 
epithelium of the host cells which must occur across 
this mucus interface. At the end of the experiment, we 
observed the capacity of cecal mucosa to repair itself. 
This might be explained by developing the chronic stage 
when the host can modulate its defensive mechanisms 
through enhancing local mucosa immune responses, and 
this assumption could be proofed by Khalafalla (2009) 
who cleared that in the absence of reinfection, the life 
cycle of the parasite in an infected host is self-limiting as 
a result of building up of immunity during propagation of 
infective agents through the course of the disease and/or a 
result of repeated infection. G3, G4, and G5 showed absence 
of any developmental stages of E. tenella accompanied 
by mild degenerative and hyperplastic changes with 
the mucosa, these finding agree with Ashraf (2011). 
The histopathological examination of liver and kidney 
samples collected from G2 showed multifocal periportal 
inflammation consisted of mononuclear cells infiltration 
mixed with eosinophils and coagulative necrosis of the 
renal tubules, these finding agree with finding reported 
by Saber (1995). The hepatic and kidney samples from 
G3, G4, and G5 showed mild to moderate periportal 
inflammatory cells infiltration and degenerative changes 
of renal tubules epithelium. There was an improvement in 
livers and kidneys of G3, G4, and G5) in comparison with G2. 
CONCLUSION
Through this trials, the use of  toltrazuril  alone  and 
in  combination with sulfaclozine was  able  to  control 
experimental caecal coccidian infection in chickens. The 
combined use of both drugs can be proven to better 
manage the infection adequately due to the improved 
effect of both drugs. But this result needs to be further 
investigated in the other species of coccidia that infect 
chickens. 
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